Showing results (171-180 of 176) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Chemical Research in Toxicology|May 29, 2010
Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosisAmit S Kalgutkar, David A Griffith, Tim Ryder, et al.Nature Communications|December 16, 2016
A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosyZhenzhen Wang, Yonghu Sun, Xi'an Fu, et al.Journal of Medicinal Chemistry|November 1, 2002
Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structureStacie S Canan Koch, Lars H Thoresen, Jayashree G Tikhe, et al.Bioorganic & Medicinal Chemistry Letters|November 17, 2012
Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitorsSamit K Bhattacharya, Gary E Aspnes, Scott W Bagley, et al.Bioorganic & Medicinal Chemistry Letters|July 24, 2009
Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonistsMary T Didiuk, David A Griffith, John W Benbow, et al.JAMA Dermatology|March 28, 2019
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With LeprosyHong Liu, Zhenzhen Wang, Fangfang Bao, et al.Pageof 18